133 related articles for article (PubMed ID: 8348290)
1. Effects of intravenous aminopropylidene bisphosphonate in patients with refractory Paget's disease.
Cormier C; Hilliquin P; Menkès CJ
Br J Rheumatol; 1993 Aug; 32(8):767-8. PubMed ID: 8348290
[No Abstract] [Full Text] [Related]
2. Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
Fritz P; Lioté F; Kuntz D
Semin Arthritis Rheum; 1994 Feb; 23(4):282. PubMed ID: 8009260
[No Abstract] [Full Text] [Related]
3. Treatment of Paget's disease of bone with single dose intravenous pamidronate.
Watts RA; Skingle SJ; Bhambhani MM; Pountain G; Crisp AJ
Ann Rheum Dis; 1993 Aug; 52(8):616-8. PubMed ID: 8215628
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Paget's disease of bone with intravenous pamidronate: comparison of 2 different modes of treatment.
Ismail AA; Fox P; Stamp TC; Dhillon V; Crisp AJ; MacGregor A
J Rheumatol; 1997 Nov; 24(11):2266-7. PubMed ID: 9375899
[No Abstract] [Full Text] [Related]
5. Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
Grauer A; Klar B; Scharla SH; Zieglar R
Semin Arthritis Rheum; 1994 Feb; 23(4):283-4. PubMed ID: 8009261
[No Abstract] [Full Text] [Related]
6. Use of the bisphosphonate space in treatment and retreatment of Paget's disease.
Stone MD; Patel S; Hosking DJ
Semin Arthritis Rheum; 1994 Feb; 23(4):278. PubMed ID: 8009256
[No Abstract] [Full Text] [Related]
7. Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels.
Ang G; Feiglin D; Moses AM
Endocr Pract; 2003; 9(4):280-3. PubMed ID: 14561571
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravenous pamidronate therapy on Paget's disease of bone.
Bombassei GJ; Yocono M; Raisz LG
Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981
[TBL] [Abstract][Full Text] [Related]
9. Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.
Cantrill JA; Buckler HM; Anderson DC
Ann Rheum Dis; 1986 Dec; 45(12):1012-8. PubMed ID: 3813665
[TBL] [Abstract][Full Text] [Related]
10. Ibandronate treatment in Paget's disease of bone.
Grauer A; Heichel S; Knaus J; Dosch E; Ziegler R
Bone; 1999 May; 24(5 Suppl):87S-89S. PubMed ID: 10321936
[No Abstract] [Full Text] [Related]
11. [Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)].
Scharla SH; Grauer A; Ziegler R
Klin Wochenschr; 1991 Jan; 69(1):25-30. PubMed ID: 2016845
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
Heynen G; Delwaide P; Bijvoet OL; Franchimont P
Eur J Clin Invest; 1982 Feb; 12(1):29-35. PubMed ID: 6802650
[No Abstract] [Full Text] [Related]
13. Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
Stuckey BG; Gutteridge DH; Stewart GO; Prince RL; Ward LC; Kent GN; Prince RI; Retallack RW; Bhagat CI; Nicholson GC
Semin Arthritis Rheum; 1994 Feb; 23(4):286. PubMed ID: 8009263
[No Abstract] [Full Text] [Related]
14. Intravenously administered pamidronate in the treatment of Paget's disease of bone.
Tucci JR; Bontha S
Endocr Pract; 2001; 7(6):423-9. PubMed ID: 11747277
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH
Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
[TBL] [Abstract][Full Text] [Related]
16. Response of biochemical markers of bone turnover to pamidronate infusion in Paget's disease of bone.
Sharp CA; Worsfold M; Rowlands PR; Davie MW
Semin Arthritis Rheum; 1994 Feb; 23(4):242-3. PubMed ID: 8009239
[No Abstract] [Full Text] [Related]
17. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
Wimalawansa SJ; Gunasekera RD
Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
[TBL] [Abstract][Full Text] [Related]
18. Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
Harinck HI; Papapoulos SE; Blanksma HJ; Moolenaar AJ; Vermeij P; Bijvoet OL
Br Med J (Clin Res Ed); 1987 Nov; 295(6609):1301-5. PubMed ID: 3120987
[TBL] [Abstract][Full Text] [Related]
19. Ototoxicity associated with intravenous bisphosphonate administration.
Reid IR; Mills DA; Wattie DJ
Calcif Tissue Int; 1995 Jun; 56(6):584-5. PubMed ID: 7648491
[TBL] [Abstract][Full Text] [Related]
20. Paget's disease of bone: five regimens of pamidronate treatment.
Pepersack T; Karmali R; Gillet C; François D; Fuss M
Clin Rheumatol; 1994 Mar; 13(1):39-44. PubMed ID: 8187442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
